These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30173664)

  • 21. Acceptability of a hypothetical dengue vaccine and the potential impact of dengue vaccination on personal vector control behavior: a qualitative study in Fortaleza, Brazil.
    Scott VK; Pinheiro MSN; Machado MMT; Castro MC
    BMC Public Health; 2023 Dec; 23(1):2408. PubMed ID: 38049772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dengue, Zika and Chikungunya].
    Kantor IN
    Medicina (B Aires); 2016; 76(2):93-7. PubMed ID: 26942903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques.
    George J; Valiant WG; Mattapallil MJ; Walker M; Huang YS; Vanlandingham DL; Misamore J; Greenhouse J; Weiss DE; Verthelyi D; Higgs S; Andersen H; Lewis MG; Mattapallil JJ
    Sci Rep; 2017 Sep; 7(1):10498. PubMed ID: 28874759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology.
    Priyamvada L; Hudson W; Ahmed R; Wrammert J
    Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.
    Willcox AC; Collins MH; Jadi R; Keeler C; Parr JB; Mumba D; Kashamuka M; Tshefu A; de Silva AM; Meshnick SR
    Am J Trop Med Hyg; 2018 Sep; 99(3):756-763. PubMed ID: 29988000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal dengue vaccination strategies of seropositive individuals.
    Shim E
    Math Biosci Eng; 2019 Feb; 16(3):1171-1189. PubMed ID: 30947414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro.
    Kawiecki AB; Christofferson RC
    J Infect Dis; 2016 Nov; 214(9):1357-1360. PubMed ID: 27521359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coinfection, Altered Vector Infectivity, and Antibody-Dependent Enhancement: The Dengue-Zika Interplay.
    Olawoyin O; Kribs C
    Bull Math Biol; 2020 Jan; 82(1):13. PubMed ID: 31933003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
    Martín-Acebes MA; Saiz JC; Jiménez de Oya N
    Front Cell Infect Microbiol; 2018; 8():44. PubMed ID: 29497604
    [No Abstract]   [Full Text] [Related]  

  • 31. Zika enhancement: a reality check.
    Mahalingam S; Teixeira MM; Halstead SB
    Lancet Infect Dis; 2017 Jul; 17(7):686-688. PubMed ID: 28653626
    [No Abstract]   [Full Text] [Related]  

  • 32. Can Vaccination Save a Zika Virus Epidemic?
    Valega-Mackenzie W; Ríos-Soto KR
    Bull Math Biol; 2018 Mar; 80(3):598-625. PubMed ID: 29359251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination strategies for SIR vector-transmitted diseases.
    Cruz-Pacheco G; Esteva L; Vargas C
    Bull Math Biol; 2014 Aug; 76(8):2073-90. PubMed ID: 25102777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host immune response against DENV and ZIKV infections.
    Sekaran SD; Ismail AA; Thergarajan G; Chandramathi S; Rahman SKH; Mani RR; Jusof FF; Lim YAL; Manikam R
    Front Cell Infect Microbiol; 2022; 12():975222. PubMed ID: 36159640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Accuracy of Parameters for Zika and Dengue Virus Infections, Singapore.
    Ho HJ; Wong JGX; Mar Kyaw W; Lye DC; Leo YS; Chow A
    Emerg Infect Dis; 2017 Dec; 23(12):2085-2088. PubMed ID: 29148371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An approach of the exact linearization techniques to analysis of population dynamics of the mosquito Aedes aegypti.
    Dos Reis CA; Florentino HO; Cólon D; Rosa SRF; Cantane DR
    Math Biosci; 2018 May; 299():51-57. PubMed ID: 29253493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seasonal temperature variation influences climate suitability for dengue, chikungunya, and Zika transmission.
    Huber JH; Childs ML; Caldwell JM; Mordecai EA
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006451. PubMed ID: 29746468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K; Perng GC
    Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Math Med Biol; 2021 Mar; 38(1):1-27. PubMed ID: 32671383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine.
    Maier SB; Huang X; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Math Biosci; 2017 Dec; 294():15-32. PubMed ID: 28935561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.